|
Jeff Hesselberg Vice President Regulatory Affairs. Mr. Hesselberg was appointed Vice President Regulatory Affairs in April 2007. He joined GTx from ICOS Corporation where from 1996 to May 2007 he served as Manager Associate Director and then Director of Regulatory Affairs. Most recently Mr. Hesselberg worked on the successful development launch and commercialization of Cialis® (tadalafil) for the treatment of erectile dysfunction. From 1984 to 1996 Mr. Hesselberg worked for Immunex Corporation and the Puget Sound Blood Center. Mr. Hesselberg holds a B.S. in Molecular Biology from the University of Wisconsin Madison and a MBA from the University of Washington. | 